Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Meibomian Gland Dysfunction
Interventions: testosterone ophthalmic solution, vehicle of testosterone ophthalmic solution; Drug
Lead sponsor: ORA, Inc.; Industry
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Traumatic Brain Injury
Interventions: Implementation Intentions(II); Other
Lead sponsor: Allina Health System; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Fort Campbell North, Kentucky

Conditions: Glioblastoma, Radiotherapy; Complications, Cognitive Decline, Chemoradiation
Interventions: Ramipril; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 422
States / cities: Anchorage, Alaska • Phoenix, Arizona • Fort Smith, Arkansas + 280 more

Conditions: Alzheimer Disease, Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD), Vascular Contributions to Cognitive Impairment and Dementia (VCID), Mixed Etiology Dementias (MED), Mild Cognitive Impairment (MCI)
Interventions: Problem Solving Training; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: College Station, Texas • Dallas, Texas • Edinburg, Texas

Conditions: Bipolar Disorder
Interventions: Memantine, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 3
States / cities: Los Angeles, California • Chicago, Illinois • Boston, Massachusetts

Conditions: Breast Cancer, Vaginal Dryness, Dyspareunia, Sexual Health Quality of Life
Interventions: Testosterone; Drug
Lead sponsor: Creighton University; Other
Eligibility: 50 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Preeclampsia Postpartum
Interventions: Aspirin 81 mg, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Peripheral Artery Disease, Endothelial Dysfunction, Autonomic Imbalance
Interventions: TVS, Sham TVS; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 85 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Traumatic Brain Injury, Post Traumatic Stress Disorder, Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Not listed
Lead sponsor: University of Southern California; Other
Eligibility: 50 Years to 90 Years
Enrollment: 289 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2021
U.S. locations: 19
States / cities: Sun City, Arizona • Irvine, California • La Jolla, California + 14 more

Conditions: Environmental Enteric Dysfunction, Zinc Deficiency, Vitamin A Deficiency
Interventions: 3 mg zinc sulfate supplement, 0.5 mg of 13C10-retinyl-acetate; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Months to 24 Months
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cognitive Disorders, HIV Infections
Interventions: Thioctic acid, Selegiline hydrochloride; Drug
Lead sponsor: The Dana Foundation; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York • Rochester, New York

Conditions: Blood Pressure, Endothelial Dysfunction
Interventions: Brief on-shift nap; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metabolic Syndrome X
Interventions: Eplerenone, Ramipril; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Ejaculatory Dysfunction, Hypogonadism
Interventions: Testosterone Solution 2%, Placebo Solution; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 26 Years and older · Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 6
States / cities: Los Angeles, California • San Diego, California • New Orleans, Louisiana + 3 more

Conditions: Alzheimer's Disease, Mild Cognitive Impairment, Prediabetic State
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years and older
Enrollment: 850 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2031
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Parkinson Disease
Interventions: Capsaicin, Resistive respiratory loads, Event-related evoked potential using electroencephalography (EEG)., Fluoroscopic swallow evaluation; Drug · Device · Other + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 45 Years to 85 Years
Enrollment: 119 participants
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Preeclampsia, Heart Failure Preserved Ejection Fraction, Hypertension
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Memory Disorders, Alzheimer Disease, Dementia, Cognitive Impairment, Frontotemporal Dementia
Interventions: COGNISION™ System; Device
Lead sponsor: Neuronetrix, Inc.; Industry
Eligibility: 60 Years to 90 Years
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 7
States / cities: West Palm Beach, Florida • Lexington, Kentucky • Louisville, Kentucky + 4 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Zanamivir; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 45 Years to 64 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Binge Eating Disorder
Interventions: Lisdexamfetamine; Drug
Lead sponsor: Lindner Center of HOPE; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Mason, Ohio

Conditions: Insomnia, Mild Cognitive Impairment
Interventions: Sleep-SMART; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Gulf War Illness, Chronic Fatigue, Ubiquinol, Coenzyme Q10
Interventions: Ubiquinol, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 35 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 4
States / cities: Miami, Florida • Boston, Massachusetts • Minneapolis, Minnesota + 1 more

Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction
Interventions: CN-105, Placebo; Drug
Lead sponsor: Miles Berger, MD PhD; Other
Eligibility: 60 Years and older
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined), Sexual Interest/Arousal Disorder (DSM-5 Defined)
Interventions: bupropion, Lorexys low-dose, Lorexys moderate-dose; Drug
Lead sponsor: S1 Biopharma, Inc.; Industry
Eligibility: 25 Years to 50 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Beachwood, Ohio • Cincinnati, Ohio

Search by objective public record fields.

Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia

Memantine and Cognitive Dysfunction in Bipolar Disorder

Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy

Aspirin and Preeclampsia

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function in PAD

A Study of Brain Aging in Vietnam War Veterans

Effects of EED on Zn Absorption and Retention in Children From a Standard Dose

A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

Night Shift Work, On-shift Napping, and Endothelial Function: A Pilot Study

Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity

A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels

Wake Forest Alzheimer's Disease Clinical Core

Airway Protective Mechanisms in PD (R01)

Exercise Testing After Preeclampsia

Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes

Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects

SleepSMART for Veterans With MCI and Insomnia

Coenzyme Q10 Phase III Trial in Gulf War Illness

Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety